Mesothelioma patients and their families are particularly vulnerable to ill-meaning “medicine salesmen”, such as the ones portrayed in this special investigation by 60 Minutes. Take a few minutes to watch these videos and please share if you have personally experienced something similar. The only way to stop these scams is to speak up.
FDA Approves KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Patients with Unresectable or Metastatic Malignant Pleural Mesothelioma
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with
